XML 67 R57.htm IDEA: XBRL DOCUMENT
v3.22.2.2

REVENUES - Net Sales from Contracts with Customers by Global Business Unit (Details) - USD ($) $ in Millions | 3 Months Ended | 9 Months Ended
--- | --- | ---
Sep. 30, 2022 | Sep. 30, 2021 | Sep. 30, 2022 | Sep. 30, 2021
Revenue From Contract With Customer [Line Items] |  |  |  |
Net sales | $ 3,773 | $ 3,226 | $ 11,226 | $ 9,270
U.S. |  |  |  |
Revenue From Contract With Customer [Line Items] |  |  |  |
Net sales | 1,849 | 1,319 | 5,370 | 3,697
International |  |  |  |
Revenue From Contract With Customer [Line Items] |  |  |  |
Net sales | 1,924 | 1,907 | 5,856 | 5,573
Renal Care |  |  |  |
Revenue From Contract With Customer [Line Items] |  |  |  |
Net sales | 942 | 981 | 2,767 | 2,867
Renal Care | U.S. |  |  |  |
Revenue From Contract With Customer [Line Items] |  |  |  |
Net sales | 240 | 222 | 690 | 655
Renal Care | International |  |  |  |
Revenue From Contract With Customer [Line Items] |  |  |  |
Net sales | 702 | 759 | 2,077 | 2,212
Medication Delivery |  |  |  |
Revenue From Contract With Customer [Line Items] |  |  |  |
Net sales | 725 | 747 | 2,141 | 2,096
Medication Delivery | U.S. |  |  |  |
Revenue From Contract With Customer [Line Items] |  |  |  |
Net sales | 475 | 490 | 1,406 | 1,345
Medication Delivery | International |  |  |  |
Revenue From Contract With Customer [Line Items] |  |  |  |
Net sales | 250 | 257 | 735 | 751
Pharmaceuticals |  |  |  |
Revenue From Contract With Customer [Line Items] |  |  |  |
Net sales | 525 | 589 | 1,574 | 1,687
Pharmaceuticals | U.S. |  |  |  |
Revenue From Contract With Customer [Line Items] |  |  |  |
Net sales | 173 | 188 | 494 | 550
Pharmaceuticals | International |  |  |  |
Revenue From Contract With Customer [Line Items] |  |  |  |
Net sales | 352 | 401 | 1,080 | 1,137
Clinical Nutrition |  |  |  |
Revenue From Contract With Customer [Line Items] |  |  |  |
Net sales | 231 | 244 | 688 | 715
Clinical Nutrition | U.S. |  |  |  |
Revenue From Contract With Customer [Line Items] |  |  |  |
Net sales | 92 | 88 | 266 | 255
Clinical Nutrition | International |  |  |  |
Revenue From Contract With Customer [Line Items] |  |  |  |
Net sales | 139 | 156 | 422 | 460
Advanced Surgery |  |  |  |
Revenue From Contract With Customer [Line Items] |  |  |  |
Net sales | 247 | 249 | 738 | 722
Advanced Surgery | U.S. |  |  |  |
Revenue From Contract With Customer [Line Items] |  |  |  |
Net sales | 141 | 135 | 428 | 405
Advanced Surgery | International |  |  |  |
Revenue From Contract With Customer [Line Items] |  |  |  |
Net sales | 106 | 114 | 310 | 317
Acute Therapies |  |  |  |
Revenue From Contract With Customer [Line Items] |  |  |  |
Net sales | 158 | 185 | 519 | 580
Acute Therapies | U.S. |  |  |  |
Revenue From Contract With Customer [Line Items] |  |  |  |
Net sales | 53 | 69 | 179 | 211
Acute Therapies | International |  |  |  |
Revenue From Contract With Customer [Line Items] |  |  |  |
Net sales | 105 | 116 | 340 | 369
BioPharma Solutions |  |  |  |
Revenue From Contract With Customer [Line Items] |  |  |  |
Net sales | 172 | 206 | 491 | 524
BioPharma Solutions | U.S. |  |  |  |
Revenue From Contract With Customer [Line Items] |  |  |  |
Net sales | 99 | 109 | 226 | 218
BioPharma Solutions | International |  |  |  |
Revenue From Contract With Customer [Line Items] |  |  |  |
Net sales | 73 | 97 | 265 | 306
Patient Support Systems |  |  |  |
Revenue From Contract With Customer [Line Items] |  |  |  |
Net sales | 380 | 0 | 1,127 | 0
Patient Support Systems | U.S. |  |  |  |
Revenue From Contract With Customer [Line Items] |  |  |  |
Net sales | 301 | 0 | 880 | 0
Patient Support Systems | International |  |  |  |
Revenue From Contract With Customer [Line Items] |  |  |  |
Net sales | 79 | 0 | 247 | 0
Front Line Care |  |  |  |
Revenue From Contract With Customer [Line Items] |  |  |  |
Net sales | 279 | 0 | 855 | 0
Front Line Care | U.S. |  |  |  |
Revenue From Contract With Customer [Line Items] |  |  |  |
Net sales | 209 | 0 | 618 | 0
Front Line Care | International |  |  |  |
Revenue From Contract With Customer [Line Items] |  |  |  |
Net sales | 70 | 0 | 237 | 0
Surgical Solutions |  |  |  |
Revenue From Contract With Customer [Line Items] |  |  |  |
Net sales | 76 | 0 | 223 | 0
Surgical Solutions | U.S. |  |  |  |
Revenue From Contract With Customer [Line Items] |  |  |  |
Net sales | 38 | 0 | 111 | 0
Surgical Solutions | International |  |  |  |
Revenue From Contract With Customer [Line Items] |  |  |  |
Net sales | 38 | 0 | 112 | 0
Other |  |  |  |
Revenue From Contract With Customer [Line Items] |  |  |  |
Net sales | 38 | 25 | 103 | 79
Other | U.S. |  |  |  |
Revenue From Contract With Customer [Line Items] |  |  |  |
Net sales | 28 | 18 | 72 | 58
Other | International |  |  |  |
Revenue From Contract With Customer [Line Items] |  |  |  |
Net sales | $ 10 | $ 7 | $ 31 | $ 21

X
- Definition Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table. + References No definition available. + Details
Name: | us-gaap_DisaggregationOfRevenueLineItems
Namespace Prefix: | us-gaap_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration

X
- Definition Amount, excluding tax collected from customer, of revenue from satisfaction of performance obligation by transferring promised good or service to customer. Tax collected from customer is tax assessed by governmental authority that is both imposed on and concurrent with specific revenue-producing transaction, including, but not limited to, sales, use, value added and excise. + References Reference 1: http://www.xbrl.org/2003/role/disclosureRef -Publisher FASB -Name Accounting Standards Codification -Topic 280 -SubTopic 10 -Section 50 -Paragraph 30 -Subparagraph (a) -URI https://asc.fasb.org/extlink&oid=126901519&loc=d3e8906-108599 Reference 2: http://www.xbrl.org/2003/role/disclosureRef -Publisher FASB -Name Accounting Standards Codification -Topic 280 -SubTopic 10 -Section 50 -Paragraph 40 -URI https://asc.fasb.org/extlink&oid=126901519&loc=d3e9031-108599 Reference 3: http://www.xbrl.org/2003/role/disclosureRef -Publisher FASB -Name Accounting Standards Codification -Topic 280 -SubTopic 10 -Section 50 -Paragraph 41 -Subparagraph (a) -URI https://asc.fasb.org/extlink&oid=126901519&loc=d3e9038-108599 Reference 4: http://www.xbrl.org/2003/role/disclosureRef -Publisher FASB -Name Accounting Standards Codification -Topic 280 -SubTopic 10 -Section 50 -Paragraph 32 -Subparagraph (b) -URI https://asc.fasb.org/extlink&oid=126901519&loc=d3e8933-108599 Reference 5: http://www.xbrl.org/2003/role/disclosureRef -Publisher FASB -Name Accounting Standards Codification -Topic 280 -SubTopic 10 -Section 50 -Paragraph 32 -Subparagraph (a) -URI https://asc.fasb.org/extlink&oid=126901519&loc=d3e8933-108599 Reference 6: http://www.xbrl.org/2003/role/disclosureRef -Publisher FASB -Name Accounting Standards Codification -Topic 606 -SubTopic 10 -Section 50 -Paragraph 4 -Subparagraph (a) -URI https://asc.fasb.org/extlink&oid=126920106&loc=SL49130543-203045 Reference 7: http://www.xbrl.org/2003/role/disclosureRef -Publisher FASB -Name Accounting Standards Codification -Topic 280 -SubTopic 10 -Section 50 -Paragraph 22 -Subparagraph (b) -URI https://asc.fasb.org/extlink&oid=126901519&loc=d3e8736-108599 Reference 8: http://www.xbrl.org/2003/role/disclosureRef -Publisher FASB -Name Accounting Standards Codification -Topic 280 -SubTopic 10 -Section 50 -Paragraph 22 -Subparagraph (a) -URI https://asc.fasb.org/extlink&oid=126901519&loc=d3e8736-108599 Reference 9: http://www.xbrl.org/2003/role/disclosureRef -Publisher FASB -Name Accounting Standards Codification -Topic 280 -SubTopic 10 -Section 50 -Paragraph 42 -URI https://asc.fasb.org/extlink&oid=126901519&loc=d3e9054-108599 Reference 10: http://www.xbrl.org/2003/role/disclosureRef -Publisher FASB -Name Accounting Standards Codification -Topic 606 -SubTopic 10 -Section 50 -Paragraph 5 -URI https://asc.fasb.org/extlink&oid=126920106&loc=SL49130545-203045 Reference 11: http://www.xbrl.org/2003/role/disclosureRef -Publisher FASB -Name Accounting Standards Codification -Topic 924 -SubTopic 10 -Section S99 -Paragraph 1 -Subparagraph (SAB Topic 11.L) -URI https://asc.fasb.org/extlink&oid=6472922&loc=d3e499488-122856 + Details
Name: | us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax
Namespace Prefix: | us-gaap_
Data Type: | xbrli:monetaryItemType
Balance Type: | credit
Period Type: | duration

X
- Details
Name: | srt_StatementGeographicalAxis=country_US
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | srt_StatementGeographicalAxis=us-gaap_NonUsMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | srt_ProductOrServiceAxis=bax_RenalMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | srt_ProductOrServiceAxis=bax_MedicationDeliveryMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | srt_ProductOrServiceAxis=bax_PharmaceuticalsMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | srt_ProductOrServiceAxis=bax_ClinicalNutritionMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | srt_ProductOrServiceAxis=bax_AdvancedSurgeryMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | srt_ProductOrServiceAxis=bax_AcuteTherapiesMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | srt_ProductOrServiceAxis=bax_BioPharmaSolutionsMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | srt_ProductOrServiceAxis=bax_PatientSupportSystemsMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | srt_ProductOrServiceAxis=bax_FrontLineCareMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | srt_ProductOrServiceAxis=bax_SurgicalSolutionsMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | srt_ProductOrServiceAxis=bax_OtherProductOrServicesMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |